Heparin indications: Difference between revisions
Jump to navigation
Jump to search
m Protected "Heparin indications" [edit=sysop:move=sysop] |
|||
| Line 4: | Line 4: | ||
* Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; | * Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; | ||
* In low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease; | * In low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease; | ||
* Prophylaxis and treatment of pulmonary embolism; | * Prophylaxis and treatment of pulmonary embolism; | ||
* Atrial fibrillation with embolization; | * Atrial fibrillation with embolization; | ||
* Diagnosis and treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation); | * Diagnosis and treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation); | ||
* Prevention of clotting in arterial and cardiac surgery; | * Prevention of clotting in arterial and cardiac surgery; | ||
* Prophylaxis and treatment of peripheral arterial embolism. | * Prophylaxis and treatment of peripheral arterial embolism. | ||
* As an anticoagulant in blood transfusions, extracorporeal circulation, dialysis procedures, and in blood samples for laboratory purposes. | * As an anticoagulant in blood transfusions, extracorporeal circulation, dialysis procedures, and in blood samples for laboratory purposes. | ||
{{FDA}} | {{FDA}} | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
{{WH}} | |||
{{WS}} | |||
Revision as of 15:17, 3 December 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Heparin sodium injection is indicated for:
- Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension;
- In low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease;
- Prophylaxis and treatment of pulmonary embolism;
- Atrial fibrillation with embolization;
- Diagnosis and treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation);
- Prevention of clotting in arterial and cardiac surgery;
- Prophylaxis and treatment of peripheral arterial embolism.
- As an anticoagulant in blood transfusions, extracorporeal circulation, dialysis procedures, and in blood samples for laboratory purposes.
Adapted from the FDA Package Insert.
Template:WH
Template:WS